Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-09-17

Clinical Trial Update: Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating two different schedules of carboplatin, paclitaxel, and gemcitabine with surgery for newly diagnosed advanced epithelial ova…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBOPLATIN (Carboplatin)
  • Gemcitabine (Gemcitabine)
  • PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Warwick Medical School | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 2 | Status: UNKNOWN